ARCHIVES

Obey Says NCI “Must Do Better,” Response Dispute GAO Conclusion

This article is from The Cancer Letter archive.

Vol. 06 No. 32 | August 8, 1980

Download PDF Visit The Full Archive

Related Articles

Synar Bill Provides FDA Regulation Of Tobacco Products

March 4, 1994

Center Grant Review Tougher, Yarbro Insists

May 23, 1975

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

Abstracts Deadline For Cancer Congress Extended To Dec. 31

December 13, 1985

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004

House committee asks GAO to investigate Klausner-era NCI contract with Harvard University.

September 9, 2005